265 related articles for article (PubMed ID: 32375569)
1. Odorranalectin modified PEG-PLGA/PEG-PBLG curcumin-loaded nanoparticle for intranasal administration.
Li X; Su J; Kamal Z; Guo P; Wu X; Lu L; Wu H; Qiu M
Drug Dev Ind Pharm; 2020 Jun; 46(6):899-909. PubMed ID: 32375569
[TBL] [Abstract][Full Text] [Related]
2. [Preparation, characterization and Calu-3 cellular uptake of three kinds of poly(b-benzyl-L-amino)block-poly(ethylene glycol) nanoparticles].
Zhou Y; Lu LN; Xin X; Huo DF; Wu HB; Qiu MF
Yao Xue Xue Bao; 2013 Apr; 48(4):560-5. PubMed ID: 23833946
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.
Fan S; Zheng Y; Liu X; Fang W; Chen X; Liao W; Jing X; Lei M; Tao E; Ma Q; Zhang X; Guo R; Liu J
Drug Deliv; 2018 Nov; 25(1):1091-1102. PubMed ID: 30107760
[TBL] [Abstract][Full Text] [Related]
4. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
5. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
8. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
9. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
10.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
11. Preparation of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles by a microchannel technology.
Guo F; Guo D; Zhang W; Yan Q; Yang Y; Hong W; Yang G
Eur J Pharm Sci; 2017 Mar; 99():328-336. PubMed ID: 28062259
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells.
Paka GD; Ramassamy C
Mol Pharm; 2017 Jan; 14(1):93-106. PubMed ID: 27744707
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
14. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
16. Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration.
Wen Z; Yan Z; Hu K; Pang Z; Cheng X; Guo L; Zhang Q; Jiang X; Fang L; Lai R
J Control Release; 2011 Apr; 151(2):131-8. PubMed ID: 21362449
[TBL] [Abstract][Full Text] [Related]
17. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
[TBL] [Abstract][Full Text] [Related]
18. Acute Damage to the Sperm Quality and Spermatogenesis in Male Mice Exposed to Curcumin-Loaded Nanoparticles.
Xia X; Wang L; Yang X; Hu Y; Liu Q
Int J Nanomedicine; 2020; 15():1853-1862. PubMed ID: 32256064
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery.
Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z
Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
